Broadly neutralizing antibody treatment may target HIV viral reservoir in monkeys

After receiving a course of antiretroviral therapy for their HIV-like infection, half of a group of monkeys infused with a broadly neutralizing antibody to HIV paired with an immune stimulatory compound suppressed the virus for over 4 months without additional treatment, according to scientists. The therapy may have targeted the viral reservoir. The addition of the immune stimulatory compound appears to have extended the duration and amount of viral suppression.